DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual filing with no material developments. Monitor the company's next earnings report for any significant updates.
Final — all horizons settled through T+60d ⚠ clustered
LYEL ▼ -43.24% at T+60d
NEUTRAL call ✗ call lost -43.24% · α vs SPY -48.01% · entry $22.62 → $12.84
T+1d
-5.00%
call -5.00% · α -4.51%
$21.49
settled 5mo ago
T+5d
-8.40%
call -8.40% · α -8.80%
$20.72
settled 5mo ago
T+20d
-27.63%
call -27.63% · α -32.59%
$16.37
settled 4mo ago
T+60d
-43.24%
call -43.24% · α -48.01%
$12.84
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Lyell Immunopharma filed a definitive proxy statement for its 2026 annual meeting, which includes routine director elections and executive compensation matters. The filing is standard for public companies and does not contain any material financial or strategic developments.
Key Facts
- Filing is a standard DEFA14A proxy statement for the 2026 annual meeting
- Covers routine matters including director elections and executive compensation
- No material financial or strategic developments disclosed
- Standard annual filing for public companies
Financial Impact
No material financial impact from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (10 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-016688 |
| Document: 0001140361-26-016688-index-headers.html | 0001140361-26-016688 |
| Document: 0001140361-26-016688-index.html | 0001140361-26-016688 |
| Document: 0001140361-26-016688.txt | 0001140361-26-016688 |
13 reports for LYEL
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | Insider Cluster | $15.49 $10.53 | ▼ −32.02% | ▼ −33.00% | $9.26 (−40.22%) |
Jul 22, 2026 10w ago | EFFECT | $12.84 $15.76 | ▲ +22.74% | ▲ +19.84% | $9.26 (−27.88%) |
Jun 15, 2026 15w ago | Insider Cluster | $12.44 $13.40 | ▲ +7.72% | ▲ +7.52% | $9.26 (−25.56%) |
Jun 12, 2026 16w ago | Press Release | $13.50 $15.01 | ▲ +11.19% | ▲ +9.41% | $9.26 (−31.41%) |
Jun 8, 2026 16w ago | Press Release | $12.31 $14.04 | ▲ +14.05% | ▲ +12.42% | $9.26 (−24.78%) |
Jun 4, 2026 17w ago | Press Release | $11.97 $14.04 | ▲ +17.29% | ▲ +15.43% | $9.26 (−22.64%) |
Apr 24, 2026 23w ago | DEFA14A | $22.62 $16.37 | ▼ −27.63% | ▼ −32.59% | $9.26 (−59.06%) |
Apr 15, 2026 24w ago | EFFECT | $23.84 $19.25 | ▼ −19.25% | ▼ −25.30% | $9.26 (−61.16%) |
Apr 3, 2026 26w ago | S-3 | $21.69 $20.72 | ▼ −4.47% | ▼ −13.45% | $9.26 (−57.31%) |
Mar 12, 2026 29w ago | Press Release | $21.25 $24.80 | ▲ +16.71% | ▲ +13.12% | $9.26 (−56.42%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Mon (38h 36m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access